Decreased pyruvate kinase M2 activity li
β
Byong Chul Yoo; Ja-Lok Ku; Sung-Hye Hong; Young-Kyoung Shin; So Yeon Park; Hark
π
Article
π
2003
π
John Wiley and Sons
π
French
β 526 KB
## Abstract Resistance to anticancer drugs is a major obstacle preventing effective treatment of disseminated cancers. Understanding the molecular basis to chemoresistance is likely to provide better treatment. Cell lines resistant to cisplatin or 5βfluorouracil (5βFU) were established from human g